Publication:
Adrenocortical carcinoma in atypical Beckwith-Wiedemann syndrome due to loss of methylation at imprinting control region 2

dc.contributor.authorBEREKET, ABDULLAH
dc.contributor.authorEKER, NURŞAH
dc.contributor.authorBAĞCI ÇULÇİ, PELİN
dc.contributor.authorDEMİRCİOĞLU, SERAP
dc.contributor.authorGÜRAN, TÜLAY
dc.contributor.authorsEltan, Mehmet; Arslan Ates, Esra; Cerit, Kivilcim; Menevse, Tuba Seven; Kaygusuz, Sare Betul; Eker, Nursah; Bagci, Pelin; Ergelen, Rabia; Turan, Serap; Bereket, Abdullah; Guran, Tulay
dc.date.accessioned2022-03-15T11:36:57Z
dc.date.accessioned2026-01-11T13:16:20Z
dc.date.available2022-03-15T11:36:57Z
dc.date.issued2020
dc.identifier.doi10.1002/pbc.28042
dc.identifier.issn1545-5017
dc.identifier.pubmedPMID: 31612591
dc.identifier.urihttps://hdl.handle.net/11424/251316
dc.language.isoeng
dc.relation.ispartofPediatric Blood & Cancer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectFemale
dc.subjectHumans
dc.subjectPrognosis
dc.subjectDNA Methylation
dc.subjectInfant
dc.subjectGenomic Imprinting
dc.subjectAdrenal Cortex Neoplasms
dc.subjectAdrenocortical Carcinoma
dc.subjectBeckwith-Wiedemann Syndrome
dc.subjectPotassium Channels, Voltage-Gated
dc.subjectTranscription Initiation Site
dc.titleAdrenocortical carcinoma in atypical Beckwith-Wiedemann syndrome due to loss of methylation at imprinting control region 2
dc.typearticle
dspace.entity.typePublication
oaire.citation.startPagee28042
oaire.citation.titlePediatric Blood & Cancer
oaire.citation.volume1

Files